Positive results of the Phase 2 study evaluating masitinib in Covid-19
08/07/2024 – AB Science today announces the results of a Phase 2 study evaluating masitinib in COVID-19
08/07/2024 – AB Science today announces the results of a Phase 2 study evaluating masitinib in COVID-19